Delivery Order SPE2DB22D1017-SPE2DB25FG7UG

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management. The firm-fixed-price contract has a ceiling value of $4,417.19 and runs through January 2, 2025. This delivery order is part of a larger Indefinite Delivery...

This federal contract award, with an ID of SPE2DX15D3404|SPE2DX24F0YMN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of Insulin Degludec Pen (U-200) 3ML. The contract has a ceiling value of $2,868.98 and a completion date of November 29, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major...

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,510.61, is for the delivery of 4562539411 INSULIN DEGLUDEC PEN (U-200) 3ML. The contract has a firm fixed price and an ultimate completion date of October 20, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,977,682 units of insulin degludec pen (U-200) 3ML, with an ultimate completion date of June 24, 2024 and a ceiling value of $3,934.74. The contract is a Delivery Order with a Firm Fixed Price pricing type. It does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of...

This federal contract award, valued at $2,201.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Insulin Degludec Pen (U-100) 3ML, a specialty medication used for diabetes management. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...

This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,930.60, is for the procurement of insulin degludec pens (U-200) in 3 milliliter sizes. The contract is a firm-fixed price delivery order with a completion date of February 20, 2024. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Humulin R 500 unit/mL KwikPen 3mL. The contract has a ceiling value of $9,258.50 and a performance period ending on December 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part...

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,045.19, is for the delivery of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management. The contract has a period of performance through October 29, 2024 and is structured as a Firm Fixed Price Delivery Order. The contracting vehicle for this award is an...

The Defense Logistics Agency Troop Support Medical awarded a $5,544.80 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4561356769 HUMULIN R 500 UNIT/ML KWIKPEN 3ML insulin injection devices. Performance will take place in Conshohocken, Pennsylvania from June 27-28, 2023. The award is associated with an existing DLA medical supplies indefinite-delivery/indefinite-quantity contract vehicle to support the procurement of pharmaceuticals...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.35, is for the supply of Insulin Degludec Pen (U-200) 3ML, a critical medical commodity for federal healthcare programs. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...